Document:

NUMBER

              W-

            	
              WARRANTS
                

            
	
              [SYMBOL]

            	
               

            

    

    

    THIS
      WARRANT WILL BE VOID

    IF
      REDEEMED OR NOT

    EXERCISED
      PRIOR TO

    5:00 P.M.
      [NEW YORK CITY] TIME

    ON
      [_____________], 2012

    

    SKYSTAR
      BIO-PHARMACEUTICAL COMPANY

    

    CUSIP
       

    

    WARRANT

    

      THIS
        CERTIFIES THAT, for value received [__________] is the registered holder
        of a
        Warrant or Warrants expiring [__________], 2012 or earlier upon redemption
        (the
        "Warrant") to purchase one-quarter (1⁄4) of fully paid and non-assessable share of
        Common Stock, par value $0.001 per share ("Shares"), of Skystar
        Bio-Pharmaceutical Company, a Nevada corporation (the "Company"), for each
        Warrant evidenced by this Warrant Certificate. The Warrant entitles the holder
        thereof to purchase from the Company such number of Shares of the Company
        at the
        price of $[_____] per 1⁄4 share (the “Warrant Price”), upon surrender of this
        Warrant Certificate accompanied by the annexed duly executed exercise form
        and
        payment of the Warrant Price at the office or agency of [__________] (the
        "Warrant Agent") (such payment to be made by check made payable to the
        Warrant Agent), but only subject to the conditions set forth herein and in
        the
        Warrant Agreement between the Company and the Warrant Agent, and only if
        (i) at
        the time a holder seeks to exercise this Warrant, a registration statement
        is
        effective with respect to the Common Stock underlying the Warrants and (ii)
        the
        Common Stock has been registered or qualified or deemed to be exempt under
        the
        securities laws of the state of residence of the holder of the
        Warrants.

    

    The
      Warrant Agreement provides that upon the occurrence of certain events, the
      Warrant Price and the number of Shares purchasable hereunder, set forth on
      the
      face hereof, may, subject to certain conditions, be adjusted.

    

    The
      Warrants are exercisable in even numbers, for whole Shares only, and no fraction
      of a Share will be issued upon any exercise of a Warrant. If the holder of
      a
      Warrant would be entitled to receive a fraction of a Share upon any exercise
      of
      a Warrant, the Company shall, upon such exercise, round up or down to the
      nearest whole number the number of Shares to be issued to such
      holder.

    

    Upon
      any
      exercise of the Warrant for less than the total number of full Shares provided
      for herein, there shall be issued to the registered holder hereof or his
      assignee a new Warrant Certificate covering the number of Shares for which
      the
      Warrant has not been exercised.

    

    Warrant
      Certificates, when surrendered at the office or agency of the Warrant Agent
      by
      the registered holder hereof in person or by attorney duly authorized in
      writing, may be exchanged in the manner and subject to the limitations provided
      in the Warrant Agreement, but without payment of any service charge, for another
      Warrant Certificate or Warrant Certificates of like tenor and evidencing in
      the
      aggregate a like number of Warrants.

    

    Upon
      due
      presentment for registration of transfer of the Warrant Certificate at the
      office or agency of the Warrant Agent, a new Warrant Certificate or Warrant
      Certificates of like tenor and evidencing in the aggregate a like number of
      Warrants shall be issued to the transferee in exchange for this Warrant
      Certificate, subject to the limitations provided in the Warrant Agreement,
      without charge except for any applicable tax or other governmental
      charge.

    

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    The
      Company and the Warrant Agent may deem and treat the registered holder as the
      absolute owner of this Warrant Certificate (notwithstanding any notation of
      ownership or other writing hereon made by anyone), for the purpose of any
      exercise hereof, of any distribution to the registered holder and for all other
      purposes, and neither the Company nor the Warrant Agent shall be affected by
      any
      notice to the contrary.

    

    This
      Warrant does not entitle the registered holder to any of the rights of a
      stockholder of the Company.

    

    [Commencing
      on the date which is 6 months from the date of the prospectus], the Company
      reserves the right to redeem the Warrant, in whole but not in part, at any
      time
      prior to its exercise, with a notice of redemption in writing to the holders
      of
      record of the Warrant, giving 30 days' notice of such redemption at any
      time after the Warrant becomes exercisable if the last sale price of the Shares
      has been at least $[_____] per share on each of 20 consecutive trading days
      within any 30 trading day period ending on the third business day prior to
      the
      30-day notice of such redemption is given. The redemption price of the Warrants
      is to be $0.01 per Warrant. Any Warrant either not exercised or tendered back
      to
      the Company by the end of the date specified in the notice of redemption shall
      be canceled on the books of the Company and have no further value except for
      the
      $0.01 redemption price.

    

    

    
      	
              By:
                SKYSTAR BIO-PHARMACEUTICAL COMPANY

               

            
	
               

              By:
                

            	
              By:
                

            
	
              
                

              

              President
                

            	
              
                
 Secretary

            

    

    

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    EXERCISE
      FORM

    

    Form
      to
      be used to exercise Warrant:

    

    Skystar
      Bio-Pharmaceutical Company

    Rm.
      10601, Jiezuo Plaza, No.4, Fenghui Road South,

    Gaoxin
      District, Xian Province, P.R. China

    Date:
      __________, 20__

    

    The
      undersigned hereby elects irrevocably to exercise all of the within Warrants
      and
      to purchase shares of Common Stock of Skystar Bio-Pharmaceutical Company and
      hereby makes payment of $_______ (at the rate of $[____] per share of Common
      Stock) in payment of the Warrant Price pursuant thereto. Please issue the Common
      Stock as to which the within Warrants are exercised in accordance with the
      instructions given below.

     

    
      	
               

            	
               

               

              Signature
                ________________________________

            
	
               

            	
              Signature
                Guaranteed

            

    

    

    

    
      	
              INSTRUCTIONS
                FOR REGISTRATION OF SECURITIES

            
	
               

              Name
                

            	
               

               

              (Print
                in Block Letters)

            	
               

            
	
              Address
                

            	
               

            	
               

            
	
               

               

            	
               

            
	
              Social
                Security or Tax Identification Number

            	
               

            
	
               

            	
               

            

    

    

    NOTICE:
      THE SIGNATURE TO THIS FORM MUST CORRESPOND WITH THE NAME AS WRITTEN UPON THE
      FACE OF THE WITHIN WARRANT CERTIFICATE IN EVERY PARTICULAR WITHOUT ALTERATION
      OR
      ENLARGEMENT OR ANY CHANGE WHATSOEVER, AND MUST BE GUARANTEED BY A BANK, OTHER
      THAN A SAVINGS BANK, OR BY A TRUST COMPANY OR BY A FIRM HAVING MEMBERSHIP ON
      A
      REGISTERED NATIONAL SECURITIES EXCHANGE.

     

    

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    ASSIGNMENT

     

    To
      Be
      Executed by the Registered Holder in Order to Assign Warrants

    

    

    For
      Value
      Received, ______________ hereby sell, assign, and transfer unto 

    

    ____________________________________________________________

    (PLEASE
      TYPE OR PRINT NAME AND ADDRESS)

    

    ____________________________________________________________

    (SOCIAL
      SECURITY OR TAX IDENTIFICATION NUMBER)

    

    
      	
              and
                be delivered to 

            	
               

            
	
               

            	
               

               

              (PLEASE
                PRINT OR TYPE NAME AND ADDRESS)

            

    

    

    of
      the
      Warrants represented by this Warrant Certificate, and hereby irrevocably
      constitute and appoint Attorney to transfer this Warrant Certificate on the
      books of the Company, with full power of substitution in the
      premises.

    

    

    
      	
              Dated:
                

            	
               

            	
            
	
               

            	
               

            	
              (SIGNATURE)

            

    

    

    THE
      SIGNATURE TO THE ASSIGNMENT OF THE SUBSCRIPTION FORM MUST CORRESPOND TO THE
      NAME
      WRITTEN UPON THE FACE OF THIS WARRANT CERTIFICATE IN EVERY PARTICULAR, WITHOUT
      ALTERATION OR ENLARGEMENT OR ANY CHANGE WHATSOEVER, AND MUST BE GUARANTEED
      BY A
      COMMERCIAL BANK OR TRUST COMPANY OR A MEMBER FIRM OF THE AMERICAN STOCK
      EXCHANGE, NEW YORK STOCK EXCHANGE, PACIFIC STOCK EXCHANGE OR CHICAGO STOCK
      EXCHANGE.SKYSTAR
      BIO-PHARMACEUTICAL COMPANY 

     

    [__________],
      2008 

     

     

    Jesup
      & Lamont Securities Corp.

    650
      Fifth
      Avenue

    New
      York,
      NY 10019

     

    Dear
      Sirs: 

     

             The
      undersigned is a holder of shares of common stock, and/or options, warrants,
      or
      other rights to acquire common stock, of Skystar Bio-Pharmaceutical Company,
      a
      Nevada corporation (the "Company"). The undersigned understands that the Company
      intends to conduct a public offering (the "Public Offering") of units (the
      "Units") consisting of common stock of the Company and/or warrants to purchase
      common stock of the Company, in an offering to be managed by Jesup & Lamont
      Securities Corporation (the "Underwriter"), pursuant to a registration statement
      which has been filed with the Securities and Exchange Commission (the "SEC")
      (such registration statement, as may be amended, is referred to herein as the
      "Registration Statement"). To induce the Underwriter and any other underwriters
      that may participate in the Public Offering to continue their efforts in
      connection with the Public Offering, the undersigned hereby agrees as follows:
      

     

             (i) During
      the period commencing on the date hereof and ending on the date which is
      12 months from the date of closing of the Public Offering (such period
      herein referred to as the "Lock-Up Period"), the undersigned will not, directly
      or indirectly, through an "affiliate" or "associate" (as such terms are defined
      in the General Rules and Regulations under the Securities Act of 1933, as
      amended (the "Securities Act")), a family member or otherwise, offer, sell,
      pledge, hypothecate, grant an option for sale, or otherwise dispose of, or
      transfer or grant any rights with respect thereto in any manner (either
      privately or publicly pursuant to Rule 144 of the General Rules and
      Regulations under the Securities Act, or otherwise) any shares of common stock
      of the Company or any other securities of the Company, including but not limited
      to any securities convertible or exchangeable into shares of common stock of
      the
      Company or options, warrants or other rights to acquire common stock of the
      Company directly or indirectly owned or controlled by the undersigned on the
      date hereof or hereafter acquired by the undersigned pursuant to a stock split,
      stock dividend, recapitalization or similar transaction or otherwise acquired
      by
      the undersigned in a private transaction (the "Securities"), or enter into
      any
      swap or any other agreement or any transaction that transfers, in whole or
      in
      part, directly or indirectly, the economic consequence of ownership of the
      common stock or other securities, whether any such swap or transaction is to
      be
      settled by delivery of common stock or other securities, in cash or otherwise,
      during the Lock-Up Period, without the Underwriter's prior written consent;
      provided,
      however,
      that
      such Securities may be sold or otherwise transferred in a private transaction
      during the Lock-Up Period so long as the acquirer of the Securities, by written
      agreement with the Underwriter entered into at the time of acquisition and
      delivered to the Underwriter prior to the consummation of such acquisition,
      agrees to be bound by the restrictions set forth in this Agreement.

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

             (ii) During
      the Lock-up Period, the undersigned agrees not to make any demand for, exercise
      any right, or file (or participate in the filing of) a registration statement
      with respect to the registration of any Securities (excluding any registration
      rights of the undersigned pursuant to any agreements entered into with the
      Company prior to the commencement of the Public Offering) without the consent
      of
      the Underwriter. 

     

             (iii) The
      undersigned agrees to enter into any agreement required by any state securities
      authority or any regulatory or other authority (including the American Stock
      Exchange) as a condition to registration of the offering in such state, if
      requested by the Underwriter. 

     

             This
      Agreement shall terminate in the event the Public Offering does not close on
      or
      before August 30, 2008. 

     

             The
      undersigned hereby agrees to the placement of a legend on the certificates
      representing the Securities to indicate the restrictions on resale of the
      Securities imposed by this agreement and/or the entry of stop transfer orders
      with the transfer agent and the registrar of the Company's securities against
      the transfer of the Securities except in compliance with this agreement. In
      the
      case of any Securities for which the undersigned is the beneficial but not
      the
      record holder, the undersigned agrees to cause the record holder to authorize
      the Company to cause the transfer agent to decline to transfer and/or to note
      stop transfer restrictions on its books and records with respect to such
      Securities. 

     

             The
      undersigned hereby represents and warrants that (a) all of the Securities
      held by such person are listed on the attached Annex 1; (b) the undersigned
      has full power and authority to enter into this letter agreement, and
      (c) the undersigned will execute any additional documents necessary or
      desirable in connection with the enforcement of this letter agreement. All
      authority herein conferred or agreed to be conferred shall survive the death
      or
      incapacity of the undersigned and any obligations of the undersigned shall
      be
      binding upon the heirs, personal representatives, successors, and assigns of
      the
      undersigned. 

     

             If
      this
      agreement is acceptable to the Underwriter, please sign the form of acceptance
      below and deliver one of the counterparts hereof to me. This will become a
      binding agreement between us upon execution by each of the parties hereto.
      

     

    [Signature
      Page Follows]

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    

    
      	
               

            	
               

            	 	
               

            	
              Very
                truly yours,

            
	
               

               

            	
               

               

            	
               

               

            	
               

               

            	
               

               

               

              
                
(Signature)

            
	
               

               

            	
               

               

            	
               

               

            	
               

               

            	
               

              
                
 (Print
                Name)

            
	
               

               

               

               

              AGREED
                to and ACCEPTED

               this            day
                of                        2008

            	
               

               

            	
               

               

            
	
               

              Jesup
                & Lamont Securities Corp.

               

            	
               

               

            	
               

               

            
	
               

              By

            	
               

               

            	
               

              
                
 Authorized
                Signature

            	
               

               

            	
               

               

            

    

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    Annex
      1

     

     

    List
      of Securities Held

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00141-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00141-of-00352.parquet"}]]